Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)

Luisa Fofi, Claudia Altamura, Marilena Marcosano, Alberto Doretti, Francesca Pistoia, Antonio Granato, Simona Guerzoni, Michele Trimboli, Licia Grazzi, Danilo Antonio Montisano, Gianluca Avino, Gabriele Sebastianelli, Carla Fasano, Elisa Maria Piella, Pierangelo Geppetti, Nicoletta Brunelli, Luigi Francesco Iannone, Fabrizio Vernieri

Open source

DOI: 10.3389/fneur.2026.1784242
Published: 2026-03-31
Container: Frontiers in Neurology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1784242,
  title = {Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)},
  author = {Luisa Fofi and Claudia Altamura and Marilena Marcosano and Alberto Doretti and Francesca Pistoia and Antonio Granato and Simona Guerzoni and Michele Trimboli and Licia Grazzi and Danilo Antonio Montisano and Gianluca Avino and Gabriele Sebastianelli and Carla Fasano and Elisa Maria Piella and Pierangelo Geppetti and Nicoletta Brunelli and Luigi Francesco Iannone and Fabrizio Vernieri},
  year = {2026},
  journal = {Frontiers in Neurology},
  doi = {10.3389/fneur.2026.1784242},
  url = {https://doi.org/10.3389/fneur.2026.1784242}
}

RIS

TY  - JOUR
TI  - Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)
AU  - Luisa Fofi
AU  - Claudia Altamura
AU  - Marilena Marcosano
AU  - Alberto Doretti
AU  - Francesca Pistoia
AU  - Antonio Granato
AU  - Simona Guerzoni
AU  - Michele Trimboli
AU  - Licia Grazzi
AU  - Danilo Antonio Montisano
AU  - Gianluca Avino
AU  - Gabriele Sebastianelli
AU  - Carla Fasano
AU  - Elisa Maria Piella
AU  - Pierangelo Geppetti
AU  - Nicoletta Brunelli
AU  - Luigi Francesco Iannone
AU  - Fabrizio Vernieri
PY  - 2026
JO  - Frontiers in Neurology
DO  - 10.3389/fneur.2026.1784242
UR  - https://doi.org/10.3389/fneur.2026.1784242
ER  -

APA

Fofi, L., Altamura, C., Marcosano, M., Doretti, A., Pistoia, F., Granato, A., Guerzoni, S., Trimboli, M., Grazzi, L., Montisano, D. A., Avino, G., Sebastianelli, G., Fasano, C., Piella, E. M., Geppetti, P., Brunelli, N., Iannone, L. F., & Vernieri, F. (2026). Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study). Frontiers in Neurology. https://doi.org/10.3389/fneur.2026.1784242

Source records

crossref · retrieved 2026-09-26T16:14:59.142Z